Thanks for that pickup Vintage.
I just went back and checked because I had thought that efficacy of diagnosing stroke location and type was a part of the stage 2 endpoints although I got that wrong.... my mistake.
Given that clarification I agree with you that a commercial distribution partnership will likely follow the validation phase.
EMvision Research Notes, page-2324
Add EMV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$2.06 |
Change
-0.060(2.83%) |
Mkt cap ! $176.1M | |||
| Open | High | Low | Value | Volume |
| $2.13 | $2.14 | $2.05 | $74.85K | 35.75K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 3500 | $2.04 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.10 | 5000 | 1 |
View Market Depth
| Last trade - 15.59pm 08/10/2024 (20 minute delay) ? |
| EMV (ASX) Chart |